Tenaya Therapeutics, Inc. (TNYA)
Last updated: 2026-10-24 15:29:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Tenaya Therapeutics, Inc. (TNYA) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $0.39, with a market capitalization of $87.00M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.36 to $1.72. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$87.00M | |
$0.39 | |
$32.00 | |
$0.36 | |
$0.39 | |
1.67M | |
2.76M | |
-- | |
$1.72 | |
$0.36 | |
-- | |
-- |
Tenaya Therapeutics, Inc. (TNYA) Latest Closing Stock Price
Tenaya Therapeutics, Inc. (TNYA) last closed at $0.39 as of 2026-10-23 23:19:00, unchanged from the previous close of $0.39.
During the latest regular trading session, TNYA traded between $0.36 and $32.00, with a volume of 1.67M shares. The closing price was near the lower end and near the lower end of its 52-week range.
Tenaya Therapeutics, Inc. (TNYA) 7-Day Stock Price Change
Over the past seven days, Tenaya Therapeutics, Inc. (TNYA) moved from $0.41 to $0.39, representing a decline of 4.51% ($0.02).
The stock traded between $0.36 and $0.43 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 3.39 million shares, down versus the previous seven-day period, indicating lower trading activity.
TNYA 52-Week Price Position
Position in Range: 2.2%
TNYA is currently trading at $0.39, placing it 2.2% of the way from its 52-week low of $0.36 to its 52-week high of $1.72. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Tenaya Therapeutics, Inc. (TNYA)?
Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.
Tenaya Therapeutics, Inc. Information
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 70 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Tenaya Therapeutics, Inc. (TNYA) Stock on MEXC
Eligible investors can buy real shares of Tenaya Therapeutics, Inc. (TNYA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Tenaya Therapeutics, Inc. (TNYA) stock price today?
2.Is TNYA stock going up or down today?
3.What is TNYA pre-market price?
4.What is TNYA after-hours price?
5.Is TNYA stock trading now?
6.Where does TNYA sit relative to its 52-week high and low?
7.What sector is Tenaya Therapeutics, Inc. in?
8.What is Tenaya Therapeutics, Inc.'s market capitalization and where is it listed?
9.How is TNYA valued in terms of P/E ratio and EPS?
10.Does Tenaya Therapeutics, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
TNYA Stock Calculator
Estimate the value between TNYA shares and USD.
TNYA Shares to USD
1.00 TNYA shares = 0.39 USD
Calculations are estimates based on the latest available price and are for reference only.


